Davide Mileto
Overview
Explore the profile of Davide Mileto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rizzo A, De Vito A, Lucis R, Mileto D, Giacomelli A
Am J Infect Control
. 2025 Feb;
53(3):411-412.
PMID: 40010874
No abstract available.
2.
Giovanetti M, Micheli V, Mancon A, Mileto D, Rizzo A
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39940789
(CHPV) is an arthropod-borne virus linked to encephalitis in humans, primarily in India. Its evolutionary dynamics and transmission pathways remain poorly understood due to limited genomic data. This study analyzed...
3.
Gervais A, Bastard P, Bizien L, Delifer C, Tiberghien P, Rodrigo C, et al.
J Exp Med
. 2024 Nov;
221(12.
PMID: 39485284
Arboviral diseases are a growing global health concern. Pre-existing autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) can underlie encephalitis due to West Nile virus (WNV) (∼40% of patients) and tick-borne...
4.
Bombaci M, Fassi E, Gobbini A, Mileto D, Cassaniti I, Pesce E, et al.
J Med Virol
. 2024 Sep;
96(9):e29923.
PMID: 39291820
Arthropod-borne viruses, such as dengue virus (DENV), pose significant global health threats, with DENV alone infecting around 400 million people annually and causing outbreaks beyond endemic regions. This study aimed...
5.
Mancon A, Gagliardi G, Giacomelli A, Vezzosi L, Gori A, Antinori S, et al.
J Travel Med
. 2024 Aug;
31(7).
PMID: 39209341
No abstract available.
6.
Mazzotta V, Nozza S, Lanini S, Moschese D, Tavelli A, Rossotti R, et al.
EBioMedicine
. 2024 Aug;
107:105289.
PMID: 39178746
Background: Severe and prolonged mpox courses have been described during the 2022-2023 outbreak. Identifying predictors of severe evolution is crucial for improving management and therapeutic strategies. We explored the predictors...
7.
Rizzo A, Giacomelli A, Moschese D, Mileto D
Infect Dis (Lond)
. 2024 Aug;
56(10):928-929.
PMID: 39105783
No abstract available.
8.
Raccagni A, Mancon A, Diotallevi S, Lolatto R, Bruzzesi E, Gismondo M, et al.
Viruses
. 2024 May;
16(5).
PMID: 38793563
A natural monkeypox virus infection may not induce sufficient neutralizing antibody responses in a subset of healthy individuals. The aim of this study was to evaluate monkeypox virus-neutralizing antibodies six...
9.
Moschese D, Raccagni A, Giacomelli A, Piralla A, Rossotti R, Raimondi A, et al.
Clin Infect Dis
. 2024 Apr;
80(1):234-236.
PMID: 38573320
No abstract available.
10.
Mancon A, Raccagni A, Gagliardi G, Moschese D, Rizzo A, Giacomelli A, et al.
Emerg Microbes Infect
. 2024 Apr;
13(1):2337666.
PMID: 38572513
(MPXV) infection confirmation needs reliable polymerase chain reaction (PCR) assays; in addition, viral clade attribution is a key factor in containment measures, considering a more severe syndrome in clade I...